A Phase I/II Combination Study of NMS-03305293 and Temozolomide in Adult Patients with Recurrent Glioblastoma
Clinical Trial Grant
Awarded By
Nerviano Medical Sciences S.r.l. (NMS S.r.l.) part of NMS Group SpA
Start Date
December 13, 2024
End Date
December 31, 2027
Awarded By
Nerviano Medical Sciences S.r.l. (NMS S.r.l.) part of NMS Group SpA
Start Date
December 13, 2024
End Date
December 31, 2027